tiprankstipranks
Trending News
More News >
Aziyo Biologics, Inc. Class A (ELUT)
:ELUT
US Market

Aziyo Biologics (ELUT) Revenue

Compare
66 Followers

Aziyo Biologics Revenue

Aziyo Biologics had a revenue of 6.03M in the quarter ending Mar 31, 2025, with 10.28%. This bring the company's revenue in the last twelve months to 23.71M, Increased -2.72%. In the fiscal year ending Dec 31, 2024, Aziyo Biologics had annual revenue of 24.38M with -1.50% growth.
Revenue (ttm)
23.71M
Revenue Growth
-18.22%
P/S Ratio
2.97
Revenue/Employee
$477,941
Employees
51
Market Cap
$72.36M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
24.38M-370.00K-1.50%
Dec 31, 2023
24.75M896.00K+3.76%
Dec 31, 2022
23.85M-23.54M-49.68%
Dec 31, 2021
47.39M4.71M+11.03%
Dec 31, 2020
42.68M-219.00K-0.51%
Dec 31, 2019
42.90M3.86M+9.90%
Dec 31, 2018
39.04M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis